When lower price cards may also help reduce the stress of higher drug fees from the short-term, they do not address the systemic concerns driving up prescription charges in the U.S. Broader policy alterations could tackle the root triggers of increasing drug price ranges, for example not enough transparency in pricing as well as the function of int